U.S. Drug Industry Debt Seen Rising - WSJ.com

U.S. Drug Industry Debt Seen Rising - WSJ.com: "Moody's Investors Service said U.S. pharmaceutical companies have ample cash, but most of it is held outside the U.S. -- making it costly to access because of the tax consequences."